{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:10:39Z","timestamp":1781061039202,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02537-3","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:10:06Z","timestamp":1747735806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["History of injection drug use in the month preceding incarceration in Iranian prisons"],"prefix":"10.1038","volume":"15","author":[{"given":"Mitra","family":"Darbandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Mehmandoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh Sadat","family":"Bazrafshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Haghdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-572X","authenticated-orcid":false,"given":"Roya Safari","family":"Faramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"2537_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","volume":"377","author":"S Fazel","year":"2011","unstructured":"Fazel, S. & Baillargeon, J. The health of prisoners. Lancet 377, 956\u2013965 (2011).","journal-title":"Lancet"},{"key":"2537_CR2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/add.13877","volume":"112","author":"S Fazel","year":"2017","unstructured":"Fazel, S., Yoon, I. A. & Hayes, A. J. Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction 112, 1725\u20131739 (2017).","journal-title":"Addiction"},{"key":"2537_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2017.12.013","volume":"54","author":"EB Cunningham","year":"2018","unstructured":"Cunningham, E. B. et al. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: the HITS-p study. Int. J. Drug Policy. 54, 18\u201325 (2018).","journal-title":"Int. J. Drug Policy"},{"key":"2537_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s11524-019-00353-5","volume":"96","author":"A Kirwan","year":"2019","unstructured":"Kirwan, A. et al. The prison and transition health (PATH) cohort study: study protocol and baseline characteristics of a cohort of men with a history of injecting drug use leaving prison in Australia. J. Urb. Health. 96, 400\u2013410 (2019).","journal-title":"J. Urb. Health"},{"key":"2537_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/07418825.2010.535553","volume":"28","author":"CA Visher","year":"2011","unstructured":"Visher, C. A., Debus-Sherrill, S. A. & Yahner, J. Employment after prison: A longitudinal study of former prisoners. Justice Q. 28, 698\u2013718 (2011).","journal-title":"Justice Q."},{"key":"2537_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/17449200600935711","volume":"2","author":"SA Kinner","year":"2006","unstructured":"Kinner, S. A. Continuity of health impairment and substance misuse among adult prisoners in Queensland, Australia. Int. J. Prison. Health. 2, 101\u2013113 (2006).","journal-title":"Int. J. Prison. Health"},{"key":"2537_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger, I. A. et al. Release from prison\u2014a high risk of death for former inmates. N. Engl. J. Med. 356, 157\u2013165 (2007).","journal-title":"N. Engl. J. Med."},{"key":"2537_CR8","first-page":"26","volume":"14","author":"R J\u00fcrgens","year":"2011","unstructured":"J\u00fcrgens, R., Nowak, M. & Day, M. HIV and incarceration: prisons and detention. Afr. J. Reprod. Gynaecol. Endoscopy. 14, 26 (2011).","journal-title":"Afr. J. Reprod. Gynaecol. Endoscopy"},{"key":"2537_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugalcdep.2012.05.008","volume":"126","author":"SA Kinner","year":"2012","unstructured":"Kinner, S. A., Jenkinson, R., Gouillou, M. & Milloy, M. J. High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend. 126, 156\u2013160 (2012).","journal-title":"Drug Alcohol Depend."},{"key":"2537_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.puhe.2021.11.020","volume":"203","author":"S Mehmandoost","year":"2022","unstructured":"Mehmandoost, S. et al. Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis. Public. Health. 203, 75\u201382 (2022).","journal-title":"Public. Health"},{"key":"2537_CR11","doi-asserted-by":"crossref","unstructured":"Shahesmaeili, A. et al. Prevalence of Symptom-based sexually transmitted infections and related factors among incarcerated men in Iran, 2013. Medical J. Islamic Repub. Iran 35 (2021).","DOI":"10.47176\/mjiri.35.185"},{"key":"2537_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14659891.2021.2018728","volume":"28","author":"Z Hosseinkhani","year":"2023","unstructured":"Hosseinkhani, Z. et al. Prevalence of alcohol consumption in most at-risk groups in Iran: a systematic review and meta-analysis. J. Subst. Use. 28, 135\u2013142 (2023).","journal-title":"J. Subst. Use"},{"key":"2537_CR13","unstructured":"Organization, W. H. Global Hepatitis Report 2024: Action for Access in low-and middle-income Countries (World Health Organization, 2024)."},{"key":"2537_CR14","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt, L. et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Global Health. 11, e659\u2013e672 (2023).","journal-title":"Lancet Global Health"},{"key":"2537_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/liv.13949","volume":"39","author":"E Day","year":"2019","unstructured":"Day, E. et al. Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework. Liver Int. 39, 20\u201330 (2019).","journal-title":"Liver Int."},{"key":"2537_CR16","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1016\/S2214-109X(23)00267-X","volume":"11","author":"AM Aghaei","year":"2023","unstructured":"Aghaei, A. M. et al. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern mediterranean region: a systematic review and meta-analysis. Lancet Global Health. 11, e1225\u2013e1237 (2023).","journal-title":"Lancet Global Health"},{"key":"2537_CR17","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/hep.28227","volume":"63","author":"A Cousien","year":"2016","unstructured":"Cousien, A. et al. Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs. Hepatology 63, 1090\u20131101 (2016).","journal-title":"Hepatology"},{"key":"2537_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12961-019-0436-z","volume":"17","author":"M Behzadifar","year":"2019","unstructured":"Behzadifar, M., Gorji, H. A., Rezapour, A. & Bragazzi, N. L. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon\u2019s multiple streams framework. Health Res. Policy Syst. 17, 1\u201310 (2019).","journal-title":"Health Res. Policy Syst."},{"key":"2537_CR19","first-page":"8","volume":"17","author":"B Mirminachi","year":"2017","unstructured":"Mirminachi, B. et al. Update on the prevalence of hepatitis C virus infection among Iranian general population: a systematic review and meta-analysis. Hepat. Monthly. 17, 8 (2017).","journal-title":"Hepat. Monthly"},{"key":"2537_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12961-019-0442-1","volume":"17","author":"M Behzadifar","year":"2019","unstructured":"Behzadifar, M. et al. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis. Health Res. Policy Syst. 17, 1\u201311 (2019).","journal-title":"Health Res. Policy Syst."},{"key":"2537_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/dar.13016","volume":"39","author":"R Saini","year":"2020","unstructured":"Saini, R. et al. Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community\u2010based study. Drug Alcohol Rev. 39, 93\u201397 (2020).","journal-title":"Drug Alcohol Rev."},{"key":"2537_CR22","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/add.12643","volume":"109","author":"F Luciani","year":"2014","unstructured":"Luciani, F. et al. A prospective study of hepatitis C incidence in Australian prisoners. Addiction 109, 1695\u20131706 (2014).","journal-title":"Addiction"},{"key":"2537_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-830","volume":"14","author":"KJ Snow","year":"2014","unstructured":"Snow, K. J., Young, J. T., Preen, D. B., Lennox, N. G. & Kinner, S. A. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs. BMC Public. Health. 14, 1\u20137 (2014).","journal-title":"BMC Public. Health"},{"key":"2537_CR24","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1111\/add.15971","volume":"117","author":"M Curtis","year":"2022","unstructured":"Curtis, M. et al. High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment. Addiction 117, 2887\u20132898 (2022).","journal-title":"Addiction"},{"key":"2537_CR25","first-page":"179","volume":"31","author":"F Mehrabi","year":"2024","unstructured":"Mehrabi, F. et al. Drug use and unsafe injection among adults who live in prisons in Iran: a systematic review and meta-analysis. Drugs: Educ. Prev. Policy. 31, 179\u2013188 (2024).","journal-title":"Drugs: Educ. Prev. Policy"},{"key":"2537_CR26","unstructured":"https:\/\/www.prisonstudies.org\/highest-to-lowest\/prison-population-total?field_region_taxonomy_tid=All#tabletop"},{"key":"2537_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12954-022-00675-9","volume":"19","author":"A Shahesmaeili","year":"2022","unstructured":"Shahesmaeili, A. et al. HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017. Harm Reduct. J. 19, 93 (2022).","journal-title":"Harm Reduct. J."},{"key":"2537_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/epirev\/mxy002","volume":"40","author":"B Moazen","year":"2018","unstructured":"Moazen, B. et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol. Rev. 40, 58\u201369 (2018).","journal-title":"Epidemiol. Rev."},{"key":"2537_CR29","doi-asserted-by":"crossref","unstructured":"Alavi, S. M., Bakhtiarinia, P., Eghtesad, M., Albaji, A. & Salmanzadeh, S. A comparative study on the prevalence and risk factors of tuberculosis among the prisoners in Khuzestan, South-west Iran. Jundishapur J. Microbiology 7 (2014).","DOI":"10.5812\/jjm.18872"},{"key":"2537_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.healthpol.2010.12.007","volume":"100","author":"AAZ Asli","year":"2011","unstructured":"Asli, A. A. Z. et al. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy. 100, 297\u2013304 (2011).","journal-title":"Health Policy"},{"key":"2537_CR31","first-page":"229","volume":"43","author":"M Ziaee","year":"2014","unstructured":"Ziaee, M., Sharifzadeh, G., Namaee, M. H. & Fereidouni, M. Prevalence of HIV and hepatitis B, C, D infections and their associated risk factors among prisoners in Southern Khorasan Province, Iran. Iran. J. Public. Health. 43, 229 (2014).","journal-title":"Iran. J. Public. Health"},{"key":"2537_CR32","first-page":"113","volume":"3","author":"Z Nokhodian","year":"2012","unstructured":"Nokhodian, Z. et al. Seroprevalence and risk factors of hepatitis C virus among juveniles in correctional center in Isfahan, Iran. Int. J. Prev. Med. 3, 113 (2012).","journal-title":"Int. J. Prev. Med."},{"key":"2537_CR33","doi-asserted-by":"crossref","unstructured":"Salem, F. et al. Prevalence and risk factors of hepatitis B virus genotype D amongst inmates in Alborz Province, Iran: a cross-sectional survey. Jundishapur J. Microbiology 6 (2013).","DOI":"10.5812\/jjm.10221"},{"key":"2537_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1108\/IJPH-09-2014-0032","volume":"11","author":"NM Wright","year":"2015","unstructured":"Wright, N. M., Tompkins, C. N. & Farragher, T. M. Injecting drug use in prison: prevalence and implications for needle exchange policy. Int. J. Prison. Health. 11, 17\u201329 (2015).","journal-title":"Int. J. Prison. Health"},{"key":"2537_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.addbeh.2012.01.019","volume":"37","author":"SA Kinner","year":"2012","unstructured":"Kinner, S. A. et al. Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addict. Behav. 37, 691\u2013696 (2012).","journal-title":"Addict. Behav."},{"key":"2537_CR36","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2105\/AJPH.2009.178467","volume":"100","author":"T Kerr","year":"2010","unstructured":"Kerr, T. et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am. J. Public Health. 100, 1449\u20131453 (2010).","journal-title":"Am. J. Public Health"},{"key":"2537_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10935-019-00574-z","volume":"41","author":"G Moradi","year":"2020","unstructured":"Moradi, G. et al. Patterns of drug use and related factors among prisoners in Iran: results from the National survey in 2015. J. Prim. Prev. 41, 29\u201338 (2020).","journal-title":"J. Prim. Prev."},{"key":"2537_CR38","first-page":"e00435","volume":"19","author":"S Jafari","year":"2019","unstructured":"Jafari, S., Moradi, G., Gouya, M. M., Zavareh, F. A. & Ghaderi, E. Predictors of drug injection in high-risk populations of prisoners with a history of tattooing: a cross-sectional study. J. Res. Health Sci. 19, e00435 (2019).","journal-title":"J. Res. Health Sci."},{"key":"2537_CR39","first-page":"1430","volume":"42","author":"P Roshanfekr","year":"2013","unstructured":"Roshanfekr, P., Farnia, M. & Dejman, M. The effectiveness of harm reduction programs in seven prisons of Iran. Iran. J. Public. Health. 42, 1430 (2013).","journal-title":"Iran. J. Public. Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02537-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:10:11Z","timestamp":1747735811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02537-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2537"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02537-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethics committee of Kerman University of Medical Sciences. All methods were carried out by relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"17469"}}